The centre for Applied Ethics was created in April 2014 as part of a broad restructuring of ethics services at the MUHC. The 9 Research Ethics Boards (REBs), as well as research ethics, support services have been part of this exercise. Changes to the REB structure come into effect April 1, 2015. These will not affect the general principles of how research involving humans is approved. However, these changes aim at increasing efficiency while maintaining high-quality review of research.
- There is one MUHC REB and 5 specialised panels
- The 5 specialised panels will conduct both Science and Ethics review and will meet twice a month on average;
- Submission deadlines are abolished;
- completeness,
- minimal quality of documents submitted and
- assess level of risk and initiate delegated review of minimal risk studies (instead of full board reviews).
- The CAE staff will conduct pre-reviews of all studies to ensure
The MUHC currently has a single REB with 5 specialized panels :
- PED
- NEUPSY
- CT1 (Oncology)
- CT2
- CTGQ
5 Panels of the MUHC-REB
Pediatrics (PED):
|
Neurosciences-Psychiatry (NEUPSY): All projects in:
|
MUHC REB Chair: Marie Hirtle MUHC - Personne Mandatée: Marie Hirtle |
||
Panels |
Co-chairs: |
REB Coordination |
PEDS |
Vincent Lajoie |
Elizabeth Craven |
NEUPSY |
Marie-Josée Brouillette, Judith Marcoux |
Kathy Laperriere |
CT1 |
Vincent Lajoie |
Kathy Laperriere |
CT2 |
Bertrand Lebouché, Thomas Maniatis, Sonya Page |
Sheldon Levy |
CTGQ |
Marie Hirtle | James Ellasus |
Schedule of REB FULLBOARD meetings
For the schedule of REB full board meetings, please see in Nagano. Note that studies that are more than minimal risk are reviewed at the fullboard.
Please enter your study in Nagano as soon as possible to initiate the review process.
See also: